TOMM34 serves as a candidate therapeutic target associated with immune cell infiltration in colon cancer

Area of Science:

• Oncology
• Immunology
• Bioinformatics

Background:

• Colon cancer is a prevalent digestive malignancy globally.
• Translocase of the outer mitochondrial membrane 34 (TOMM34) is an oncogene linked to tumor proliferation.
• The relationship between TOMM34 and immune cell infiltration in colon cancer remains unexplored.

Purpose of the Study:

• To investigate the prognostic value of TOMM34 in colon cancer.
• To evaluate the correlation between TOMM34 expression and immune cell infiltration.
• To assess TOMM34 as a potential biomarker for colon cancer.

Main Methods:

• Integrated bioinformatics analysis using multiple open online databases.
• Evaluation of TOMM34 gene and protein expression levels.
• Survival analysis and correlation studies with immune cell markers.

Main Results:

• TOMM34 expression was significantly elevated in colon tumor tissues compared to normal tissues.
• Higher TOMM34 expression was associated with poorer survival outcomes in colon cancer patients.
• Increased TOMM34 expression correlated with decreased infiltration of B cells, CD8+ T cells, neutrophils, dendritic cells, and immune checkpoint molecules (PD-1, PD-L1, CTLA-4).

Conclusions:

• High TOMM34 expression in tumor tissue is linked to immune cell infiltration and adverse prognosis in colon cancer.
• TOMM34 shows potential as a prognostic biomarker for colon cancer diagnosis and prediction.